Healthcare -
Biotechnology - NASDAQ - BM
$ 21.98
8.38 %
$ 1.6 B
Market Cap
-36.63
P/E
KNSA - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity KNSA - Kiniksa Pharmaceuticals, Ltd.
526 M
LAST VALUE
68.48%
2 YEAR CAGR
40.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR